STOCK TITAN

Natera to Report its Third Quarter 2024 Results on November 12, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Natera, a global leader in cell-free DNA and genetic testing, has announced it will release its third quarter 2024 financial results on November 12, 2024, after market close. The company will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) on the same day. Investors can access the call through domestic (1-888-770-7321) or international (1-929-201-7107) dial-in numbers using conference ID 7684785.

Natera, un leader globale nei test genetici e nel DNA libero da cellule, ha annunciato che pubblicherà i risultati finanziari del terzo trimestre 2024 il 12 novembre 2024, dopo la chiusura del mercato. L'azienda organizzerà una conferenza telefonica e un webcast alle 13:30 PT (16:30 ET) lo stesso giorno. Gli investitori possono accedere alla chiamata tramite numeri nazionali (1-888-770-7321) o internazionali (1-929-201-7107) utilizzando l'ID conferenza 7684785.

Natera, un líder mundial en pruebas genéticas y de ADN libre de células, ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el 12 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica y una transmisión web a la 1:30 p.m. PT (4:30 p.m. ET) el mismo día. Los inversores pueden acceder a la llamada a través de números nacionales (1-888-770-7321) o internacionales (1-929-201-7107) utilizando el ID de conferencia 7684785.

네이테라, 세포 유래 DNA 및 유전자 검사 분야의 글로벌 리더,는 2024년 3분기 재무 결과를 2024년 11월 12일 장 마감 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 1시 30분 PT(오후 4시 30분 ET)에 컨퍼런스 콜 및 웹캐스트를 개최합니다. 투자자는 국내 전화번호(1-888-770-7321) 또는 국제 전화번호(1-929-201-7107)를 사용하여 컨퍼런스 ID 7684785로 전화를 통해 참여할 수 있습니다.

Natera, un leader mondial dans les tests génétiques et l'ADN libre de cellules, a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 le 12 novembre 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique et un webinaire le même jour à 13h30 PT (16h30 ET). Les investisseurs peuvent accéder à l'appel via des numéros nationaux (1-888-770-7321) ou internationaux (1-929-201-7107) en utilisant l'ID de conférence 7684785.

Natera, ein weltweit führendes Unternehmen im Bereich zellfreier DNA- und Gentests, hat angekündigt, dass es am 12. November 2024, nach Marktschluss, die finanziellen Ergebnisse des dritten Quartals 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr PT (16:30 Uhr ET) eine Telefonkonferenz und ein Webcast veranstalten. Investoren können über unter nationale (1-888-770-7321) oder internationale (1-929-201-7107) Telefonnummern auf den Anruf zugreifen, indem sie die Konferenz-ID 7684785 verwenden.

Positive
  • None.
Negative
  • None.

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its third quarter ended Sept. 30, 2024, after the market closes on Nov. 12, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).

Earnings Conference Call Information:

Event:                     

Natera’s Third Quarter 2024 Financial Results

Date:                      

Tuesday, Nov. 12, 2024

Time:                      

1:30 p.m. PT (4:30 p.m. ET)

Live Dial-In:           

1-888-770-7321 (Domestic)

 

1-929-201-7107 (International)

Conference ID:      

7684785

Webcast:                  

https://events.q4inc.com/attendee/883846048

A webcast replay will be available at investor.natera.com.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 200 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Source: Natera, Inc.

FAQ

When will Natera (NTRA) report Q3 2024 earnings?

Natera will report its third quarter 2024 earnings on November 12, 2024, after the market closes.

How can I join Natera's (NTRA) Q3 2024 earnings call?

You can join the earnings call on November 12, 2024, at 1:30 p.m. PT by dialing 1-888-770-7321 (domestic) or 1-929-201-7107 (international) with conference ID 7684785, or via webcast.

What time is Natera's (NTRA) Q3 2024 earnings call?

Natera's Q3 2024 earnings call is scheduled for 1:30 p.m. PT (4:30 p.m. ET) on November 12, 2024.

Natera, Inc.

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Stock Data

20.49B
126.45M
3.53%
93.18%
3.01%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
AUSTIN